Biogen (BIIB) Other Working Capital Changes (2009 - 2026)

Biogen (BIIB) has reported Other Working Capital Changes for 18 consecutive years, with $89.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 66.36% year-over-year to $89.0 million; the TTM figure through Mar 2026 stood at $96.1 million (up 276.86% YoY), while the FY2025 annual figure was $60.6 million, up 115.66% from the prior year.
• Other Working Capital Changes came in at $89.0 million for Q1 2026 at Biogen, up from -$119.3 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $213.6 million in Q1 2022, with the low at -$149.9 million in Q3 2022.
• Average Other Working Capital Changes over 5 years is $11.8 million, with a median of $22.0 million recorded in 2025.
• Across the five-year window, Other Working Capital Changes plunged 1445.36% in 2022 and jumped 379.89% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at $34.9 million in 2022, then plunged by 291.4% to -$66.8 million in 2023, then surged by 43.71% to -$37.6 million in 2024, then slumped by 217.29% to -$119.3 million in 2025, then surged by 174.6% to $89.0 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $89.0 million, -$119.3 million, and $104.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.